Filter
691
Filtered Results: 691
Text search:
insulina
Featured
Recommendations
90
New Publications
215
Language
Document type
No document type
335
Guidelines
156
Studies & Reports
112
Manuals
37
Fact sheets
18
Strategic & Response Plan
12
Infographics
10
Training Material
5
Resource Platforms
3
Brochures
2
Videos
1
Countries / Regions
Global
68
India
40
Latin America and the Carribbean
20
Ethiopia
19
Kenya
17
South Africa
16
Paraguay
15
Philippines
12
Bangladesh
12
Indonesia
12
Nepal
11
Rwanda
10
Venezuela
10
Germany
10
Western and Central Europe
10
Tanzania
9
Congo, Democratic Republic of
9
Uganda
9
Chile
8
Syria
8
Malawi
8
North America
8
Argentina
8
Namibia
8
Ukraine
7
Mozambique
7
Haiti
7
Nigeria
6
South–East Asia Region
6
Bolivia
6
Brazil
6
Ghana
5
Sierra Leone
5
Senegal
5
Peru
5
Africa
5
Zambia
5
Burkina Faso
4
Guinea
4
Asia
4
Eastern Europe and Central Asia
4
Liberia
4
Eswatini/ Swaziland
4
Lesotho
3
Zimbabwe
3
Colombia
2
Cambodia
2
Côte d’Ivoire / Ivory Coast
2
Chad
2
Botswana
2
Myanmar / Burma
2
Tajikistan
1
Turkey
1
Benin
1
Kazakhstan
1
Cameroon
1
Fiji
1
USA
1
Guinea-Bissau
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Jamaica
1
United Kingdom
1
Spain
1
Azerbaijan
1
East and Southern Africa
1
Latvia
1
Eastern Europe
1
Moldova
1
Russia
1
Central African Republic
1
Mali
1
Angola
1
Libya
1
Bhutan
1
South Sudan
1
Somalia
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
314
Clinical Guidelines
104
Public Health
101
Women & Child Health
23
Key Resources
12
Capacity Building
9
Pharmacy & Technologies
6
Toolboxes
NCDs
102
Pharmacy
55
Mental Health
38
COVID-19
30
Refugee
28
Caregiver
23
Conflict
20
HIV
16
TB
16
Planetary Health
10
Ebola & Marburg
9
Disability
7
NTDs
7
Global Health Education
7
AMR
6
Rapid Response
5
Health Financing Toolbox
4
Natural Hazards
3
Polio
2
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden of communicable and noncommunicable diseases and rapid urbanizat...
Mortality and burden of disease attributable to selected major risks
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance...
Infectious Diseases in Ukraine
recommended
Data on Infectious Diseases in Ukraine Now Available as a Free eBook to Help Medics and Relief Efforts During the War.
• Data on the 215+ infectious diseases endemic to Ukraine
• All published data on infections imported into Ukraine
To download the book, please click the button below and use...
The list of emergency medicine has been developed though various consultative meeting and workshops with concerned health professionals and institutions. The medicines in the list should be administered to emergency patients only treated in the health institutions, purchased from legal medicine reta...
Organizing and Delivering High Quality Care for Chronic Noncommunicable Diseases in the Americas
This 2015 edition not only updates important changes published in the MEC fifth edition, but also includes several user-friendly features and additional supplemental information, in response to requests WHO has received from stakeholders and partners.
WHO list of priority medical devices for management of cardiovascular diseases and diabetes
recommended
This publication was developed in response to the need for a reference list of priority medical devices required for management of noncommunicable diseases (NCDs), focusing on cardiovascular diseases and diabetes, especially for low- and middle-income countries to support universal health coverage a...
Rapport de synthèseHT
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
